Shanghai (1)

HER2 Positive Early Breast Cancer (1)

Recruiting (1)

phase 3 (1)

Fudan University (1)

carboplatin (1)

cyclophosphamide (1)

docetaxel (1)

epirubicin (1)

pertuzumab (1)

trastuzumab (1)

drug (1)

Other (1)

Interventional (1)

her2 positive early breast cancer

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Recruiting

Shanghai, Shanghai, China

Fudan University Shanghai Cancer Center Shanghai, China, 200032

Jun 6, 2023